Turunen; Janne Juha

Patent Applications and Registrations

Patent applications and USPTO patent grants for Turunen; Janne Juha.The latest application filed is for "antisense rna editing oligonucleotides comprising cytidine analogs".

Company Profile

13.7.15

Turunen; Janne Juha - Leiden NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antisense Rna Editing Oligonucleotides Comprising Cytidine Analogs App 20220307023 - Turunen; Janne Juha ; et al.	2022-09-29
Oligonucleotide complexes for use in RNA editing Grant 11,274,300 - Aalto , et al. March 15, 2	2022-03-15
Oligonucleotides To Treat Eye Disease App 20210401871 - Van Diepen; Hester Catharina ; et al.	2021-12-30
Single-stranded Rna-editing Oligonucleotides App 20210340529 - Turunen; Janne Juha ; et al.	2021-11-04
Oligonucleotides to treat eye disease Grant 11,123,360 - Van Diepen , et al. September 21, 2	2021-09-21
Chemically Modified Single-stranded Rna-editing Oligonucleotides App 20210238597 - Turunen; Janne Juha ; et al.	2021-08-05
Single-stranded RNA-editing oligonucleotides Grant 10,988,763 - Turunen , et al. April 27, 2	2021-04-27
Antisense Oligonucleotides For Rna Editing App 20210079393 - Boudet; Julien Auguste Germain ; et al.	2021-03-18
Chemically modified single-stranded RNA-editing oligonucleotides Grant 10,941,402 - Turunen , et al. March 9, 2	2021-03-09
Nucleic Acid Molecules For Pseudouridylation App 20210010002 - Klein; Bart ; et al.	2021-01-14
Use Of Single-stranded Antisense Oligonucleotide In Prevention Or Treatment Of Genetic Diseases Involving A Trinucleotide Repeat Expansion App 20200362348 - Adamson; Peter ; et al.	2020-11-19
Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion Grant 10,760,076 - Adamson , et al. Sep	2020-09-01
Oligonucleotides To Treat Eye Disease App 20200237802 - Van Diepen; Hester Catharina ; et al.	2020-07-30
Antisense Oligonucleotides For The Treatment Of Eye Disease App 20200181616 - Van Diepen; Hester Catharina ; et al.	2020-06-11
Oligonucleotides to treat eye disease Grant 10,617,707 - Van Diepen , et al.	2020-04-14
Antisense oligonucleotides for the treatment of eye disease Grant 10,612,025 - Van Diepen , et al.	2020-04-07
Oligonucleotides To Treat Eye Disease App 20190381089 - VAN DIEPEN; Hester Catharina ; et al.	2019-12-19
Oligonucleotide Complexes For Use In Rna Editing App 20190352641 - Aalto; Antti ; et al.	2019-11-21
Single-stranded Rna-editing Oligonucleotides App 20190330622 - Turunen; Janne Juha ; et al.	2019-10-31
Antisense Oligonucleotides For The Treatment Of Eye Disease App 20190256847 - Van Diepen; Hester Catharina ; et al.	2019-08-22
Chemically Modified Single-stranded Rna-editing Oligonucleotides App 20190218552 - Turunen; Janne Juha ; et al.	2019-07-18
Use Of Single-stranded Antisense Oligonucleotide In Prevention Or Treatment Of Genetic Diseases Involving A Trinucleotide Repeat Expansion App 20180282724 - Adamson; Peter ; et al.	2018-10-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.